Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/03/2023 | 43.15% | Truist Securities | $16 → $14 | Maintains | Buy |
11/03/2023 | 5.32% | Goldman Sachs | $12 → $10.3 | Maintains | Neutral |
11/02/2023 | 12.47% | JP Morgan | $13 → $11 | Maintains | Neutral |
11/02/2023 | 84.05% | Needham | → $18 | Reiterates | Buy → Buy |
10/06/2023 | 12.47% | Barclays | $13 → $11 | Maintains | Equal-Weight |
08/16/2023 | 84.05% | Needham | → $18 | Reiterates | Buy → Buy |
08/04/2023 | 84.05% | Needham | → $18 | Reiterates | Buy → Buy |
02/23/2023 | 73.82% | Deutsche Bank | $15 → $17 | Upgrades | Hold → Buy |
02/23/2023 | 84.05% | Needham | → $18 | Reiterates | → Buy |
02/17/2023 | 73.82% | Wells Fargo | $20 → $17 | Maintains | Overweight |
02/17/2023 | 22.7% | Goldman Sachs | $14 → $12 | Maintains | Neutral |
02/17/2023 | 43.15% | Credit Suisse | $17 → $14 | Maintains | Outperform |
02/17/2023 | 84.05% | Raymond James | $21 → $18 | Maintains | Outperform |
02/17/2023 | 84.05% | Needham | → $18 | Maintains | Buy |
01/17/2023 | 58.49% | B of A Securities | → $15.5 | Upgrades | Neutral → Buy |
11/07/2022 | 53.37% | Goldman Sachs | $17 → $15 | Maintains | Neutral |
11/04/2022 | 43.15% | Barclays | $17 → $14 | Maintains | Equal-Weight |
11/04/2022 | 114.72% | Raymond James | $24 → $21 | Maintains | Outperform |
11/04/2022 | 84.05% | Needham | $21 → $18 | Maintains | Buy |
10/06/2022 | 53.37% | RBC Capital | $18 → $15 | Maintains | Sector Perform |
07/13/2022 | 114.72% | Wells Fargo | → $21 | Initiates Coverage On | → Overweight |
07/06/2022 | 73.82% | B of A Securities | $16 → $17 | Upgrades | Underperform → Neutral |
07/01/2022 | 73.82% | Barclays | $18 → $17 | Maintains | Equal-Weight |
06/06/2022 | 84.05% | RBC Capital | $16 → $18 | Downgrades | Outperform → Sector Perform |
05/17/2022 | 84.05% | Barclays | $22 → $18 | Maintains | Equal-Weight |
05/11/2022 | 84.05% | Goldman Sachs | $20 → $18 | Maintains | Neutral |
05/10/2022 | 63.6% | RBC Capital | $20 → $16 | Maintains | Outperform |
05/10/2022 | 145.4% | Raymond James | $27 → $24 | Maintains | Outperform |
05/10/2022 | 135.17% | Credit Suisse | $30 → $23 | Maintains | Outperform |
05/10/2022 | 114.72% | Needham | $28 → $21 | Maintains | Buy |
03/30/2022 | 104.5% | Deutsche Bank | → $20 | Initiates Coverage On | → Hold |
01/24/2022 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
11/05/2021 | 145.4% | RBC Capital | $30 → $24 | Maintains | Outperform |
11/05/2021 | 176.07% | Raymond James | $26 → $27 | Maintains | Outperform |
08/06/2021 | 155.62% | Barclays | $28 → $25 | Maintains | Overweight |
06/10/2021 | 165.85% | Raymond James | → $26 | Upgrades | Market Perform → Outperform |
03/26/2021 | 206.75% | Needham | → $30 | Initiates Coverage On | → Buy |
03/23/2021 | — | Raymond James | Initiates Coverage On | → Market Perform | |
10/09/2020 | 237.42% | Jefferies | $30 → $33 | Maintains | Buy |
07/27/2020 | 216.97% | SunTrust Robinson Humphrey | → $31 | Initiates Coverage On | → Buy |
07/27/2020 | 216.97% | Stephens & Co. | → $31 | Initiates Coverage On | → Overweight |
07/27/2020 | 196.52% | B of A Securities | → $29 | Initiates Coverage On | → Buy |
07/27/2020 | 145.4% | JP Morgan | → $24 | Initiates Coverage On | → Neutral |
07/27/2020 | 176.07% | Wells Fargo | → $27 | Initiates Coverage On | → Equal-Weight |
07/27/2020 | 206.75% | Jefferies | → $30 | Initiates Coverage On | → Buy |
07/27/2020 | 176.07% | Goldman Sachs | → $27 | Initiates Coverage On | → Neutral |
07/27/2020 | 206.75% | BMO Capital | → $30 | Initiates Coverage On | → Outperform |
07/27/2020 | 216.97% | RBC Capital | → $31 | Initiates Coverage On | → Outperform |
07/27/2020 | 206.75% | Credit Suisse | → $30 | Initiates Coverage On | → Outperform |
07/27/2020 | 206.75% | Deutsche Bank | → $30 | Initiates Coverage On | → Buy |
What is the target price for Dun & Bradstreet Hldgs (DNB)?
The latest price target for Dun & Bradstreet Hldgs (NYSE: DNB) was reported by Truist Securities on November 3, 2023. The analyst firm set a price target for $14.00 expecting DNB to rise to within 12 months (a possible 43.15% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dun & Bradstreet Hldgs (DNB)?
The latest analyst rating for Dun & Bradstreet Hldgs (NYSE: DNB) was provided by Truist Securities, and Dun & Bradstreet Hldgs maintained their buy rating.
When is the next analyst rating going to be posted or updated for Dun & Bradstreet Hldgs (DNB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dun & Bradstreet Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dun & Bradstreet Hldgs was filed on November 3, 2023 so you should expect the next rating to be made available sometime around November 3, 2024.
Is the Analyst Rating Dun & Bradstreet Hldgs (DNB) correct?
While ratings are subjective and will change, the latest Dun & Bradstreet Hldgs (DNB) rating was a maintained with a price target of $16.00 to $14.00. The current price Dun & Bradstreet Hldgs (DNB) is trading at is $9.78, which is out of the analyst's predicted range.